| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |